ClinicalTrials.gg
CompletedNCT07899112Updated Oct 27, 2026

Manipulating Temporal Expectations to Accelerate Recovery After Cataract Surgery

An interventional study of Faster-timeline video and healing-attention surveys and Standard-timeline video and matched surveys in Cataract, sponsored by Harvard University. Completed at 2 sites in United States. Open to participants aged 60 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Harvard University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Oct 2024, registered Oct 2026).
Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
147
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Study summary

This study tested whether changing how quickly patients expect to heal after cataract surgery changes how quickly their vision recovers. Adults having cataract surgery in both eyes were randomly assigned to one of two groups. Both groups watched a short video of their surgeon before each surgery and completed short daily surveys afterwards. In one group, the video gave somewhat faster recovery timeframes and the surveys asked patients to notice day-to-day changes in their vision. In the other group, the video gave standard recovery timeframes and the surveys asked about activities and mood. Visual acuity was measured at routine clinic visits 1 day, 1 to 2 weeks, and 3 months after surgery.

Read the detailed description

Two-arm, parallel-group randomized trial with an active control. Patients scheduled for bilateral cataract surgery with one surgeon at two ophthalmology practices completed an online enrollment survey, which included informed consent, and were then randomized using a computer-generated sequence applied in order of enrollment.

The enrollment survey collected demographics, the 14-item Perceived Stress Scale, the Hospital Anxiety and Depression Scale, the 14-item Langer Mindfulness Scale, the Ten-Item Personality Inventory, a three-item study-specific measure of general healing expectations, and the NEI-VFQ-25.

One day before each surgery, participants watched a preoperative video of their surgeon and answered multiple-choice questions about its content. Beginning 48 hours after each surgery, participants received up to 10 daily surveys. Clinic staff measured visual acuity at baseline and at routine follow-up visits. Participants completed the NEI-VFQ-25 again 3 months after surgery and were then debriefed.

Participants were told the study concerned psychological factors and recovery after cataract surgery; the specific hypothesis was disclosed at debriefing. The surgeon and clinic staff who measured visual acuity were not told participants' assigned group.

Planned enrollment was 180. Enrollment closed at 147 because recruitment was slower than planned. The study was registered after data collection was complete.

02

Conditions studied

  • Cataract

Browse trials for

Keywords

  • expectations
  • attention
  • placebo effect
  • postoperative recovery
  • visual acuity
  • mind-body
03

In context

Cataract

1,629 studies on the registry are indexed under Cataract; 235 are open to participants now.

This study's enrollment of 147 is above the median of 79 across 1,092 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Harvard University is the lead sponsor of 50 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for bilateral cataract surgery with the participating surgeon; within the approved age range

Exclusion criteria

Exclusion Criteria:

  • Rare complications or exceptionally severe cataract, as judged by the surgeon; significant pre-existing, vision-limiting retinal or corneal pathology
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
147 participants (actual)

Study arms

  • Experimental
    Fast Healing

    Preoperative video giving recovery timeframes shifted earlier than standard, followed by daily surveys directing attention to day-to-day changes in healing.

    Behavioral: Faster-timeline video and healing-attention surveys

  • Active comparator
    Standard healing

    Preoperative video giving standard recovery timeframes, followed by daily surveys of matched length asking about activities and mood.

    Behavioral: Standard-timeline video and matched surveys

Interventions

  • BehavioralFaster-timeline video and healing-attention surveys

    Preoperative video of the participant's surgeon giving recovery timeframes shifted earlier than standard: blurry vision for 24 to 48 hours; noticeable improvement within 24 hours and by 5 to 7 days; irritation and light sensitivity resolving within 7 to 14 days. Watched 1 day before each surgery, followed by quiz questions on the timeframes. Then up to 10 daily surveys after each surgery, starting 48 hours post-surgery, asking participants to rate changes in vision, discomfort and daily function compared with the previous day.

  • BehavioralStandard-timeline video and matched surveys

    Preoperative video of the same surgeon giving standard recovery timeframes: blurry vision for up to 48 hours; noticeable improvement within 48 hours and by 1 week; irritation and light sensitivity resolving within a couple of weeks. Same schedule and quiz format. Then up to 10 daily surveys after each surgery, matched in number and length, asking about activities, rest and current mood, not healing.

06

What researchers measure

Primary outcomes

  1. Change in best-corrected visual acuity at 1 day

    Snellen acuity from the routine clinic exam, converted to logMAR; change from preoperative baseline, averaged across both eyes. Lower values indicate better acuity.

    Time frame: Baseline to 1 day after each surgery

  2. Change in best-corrected visual acuity at 1 to 2 weeks

    Snellen acuity from the routine clinic exam, converted to logMAR; change from preoperative baseline, averaged across both eyes. Lower values indicate better acuity.

    Time frame: Baseline to 1 to 2 weeks after each surgery

Secondary outcomes

  1. Change in best-corrected visual acuity at 3 months

    Same measure and scoring as the primary outcomes.

    Time frame: Baseline to 3 months after the second surgery

  2. Change in NEI-VFQ-25 composite score

    National Eye Institute Visual Function Questionnaire, 25 items; composite scored 0 to 100, higher indicates better visual function.

    Time frame: Enrollment to 3 months after the first surgery

07

Study locations

2 sites
  • Ophthalmic Consultants of Boston
    Boston, Massachusetts 02114, United States
  • Ophthalmic Consultants of Vermont
    South Burlington, Vermont 05403, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified participant-level data underlying the reported analyses, together with the analysis code, are available in a public repository (Zenodo, DOI 10.5281/zenodo.22655124).

Supporting information: Analytic code

Time frame: Available from publication of the primary results, with no end date.

Access criteria: Open access; no application required.

Data sharing details ↗ · doi.org

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07899112
Lead sponsor
Harvard University
Collaborators
Ophthalmic Consultants of Boston, Ophthalmic Consultants of Vermont
Responsible party
Peter Aungle (Postdoctoral Research Fellow, Harvard University) — Principal investigator
First posted
Oct 27, 2026
Start date
Oct 5, 2024
Primary completion
Apr 28, 2026
Completion
Jul 6, 2026
Last update
Oct 27, 2026

Study contacts

Peter J Aungle, Ph.D.
principal investigator · Harvard University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion